# Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

> **NCT07631793** · PHASE1 · RECRUITING · sponsor: **Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.** · enrollment: 76 (estimated)

## Conditions studied

- Malignant Neoplasms

## Interventions

- **DRUG:** YKYY031 group (the first stage)
- **DRUG:** YKYY031 group (the second stage)

## Key facts

- **NCT ID:** NCT07631793
- **Lead sponsor:** Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2027-12-08
- **Final completion:** 2030-12-07
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631793, "Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07631793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*